ABIOMED, Inc. Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	53
ISBN Number	not applicable
Product Code	GMD04884

Price

£505.00
approximately: $750 | €594

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a ABIOMED, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook - Cardiovascular Devices
- 2.5 SWOT Snapshot
3 ABIOMED, Inc. Pipeline Products
- 3.1 ABIOMED, Inc. Product Pipeline Analysis
  - 3.1.1 ABIOMED, Inc. Pipeline Products By Equipment Type
  - 3.1.2 ABIOMED, Inc. Pipeline Products By Development Stage
  - 3.1.3 ABIOMED, Inc. Pipeline Products By Therapy Area
  - 3.1.4 ABIOMED, Inc. Pipeline Products By Clinical Trials
  - 3.1.5 ABIOMED, Inc. Pipeline Products By News Summary
- 3.2 AbioCor II
  - 3.2.1 Product Description
  - 3.2.2 Product Status
  - 3.2.3 Clinical Trials
  - 3.2.4 Product Milestone
  - 3.2.5 Product Patent Details
- 3.3 Impella 2
  - 3.3.1 Product Description
  - 3.3.2 Product Status
  - 3.3.3 Clinical Trials
  - 3.3.4 Product Milestone
- 3.4 Impella 5
  - 3.4.1 Product Description
  - 3.4.2 Product Status
  - 3.4.3 Clinical Trials
  - 3.4.4 Product Milestone
- 3.5 Impella Pediatric Pump
  - 3.5.1 Product Description
  - 3.5.2 Product Status
- 3.6 AB5000 Portable Circulatory Support Driver
  - 3.6.1 Product Description
  - 3.6.2 Product Status
  - 3.6.3 Product Milestone
- 3.7 Impella Implantable
  - 3.7.1 Product Description
  - 3.7.2 Product Status
4 Business Description
- 4.1 Business Overview
- 4.2 Research, Development and Sale of Medical Devices
  - 4.2.1 Overview
  - 4.2.2 Financials
  - 4.2.3 Market View
  - 4.2.4 Key Strategies
- 4.3 Major Products and Services
  - 4.3.1 Overview
5 History
6 Competitors
7 Key Employees
8 Key Employee Biographies
9 Company Statement
10 Locations And Subsidiaries
- 10.1 Head Office
- 10.2 Other Locations & Subsidiaries
11 Financial Deals Landscape
- 11.1 Acquisition
  - 11.1.1 ABIOMED Acquires Impella Cardiosystems
- 11.2 IPO
  - 11.2.1 Abiomed Completes Public Offering Of Common Stock
  - 11.2.2 Abiomed Announces Secondary Offering
12 Recent Developments
- 12.1 Strategy and Business Planning
  - 12.1.1 Dec 31, 2007: Abiomed Announces Expansion In European Markets
  - 12.1.2 Dec 19, 2007: WorldHeart Enters Strategic Alliance With Abiomed
- 12.2 Financial Announcements
  - 12.2.1 May 21, 2008: Abiomed Reports Q4 Fiscal 2008 Results
  - 12.2.2 Feb 07, 2008: Abiomed Reports Q3 Fiscal 2008 Results
  - 12.2.3 Nov 08, 2007: Abiomed Reports Q2 Fiscal 2008 Results
  - 12.2.4 Aug 09, 2007: Abiomed Reports Q1 Fiscal 2008 Results
  - 12.2.5 May 17, 2007: Abiomed Reports Q4 Fiscal 2007 Results
  - 12.2.6 Apr 26, 2007: Abiomed Announces Partial Exercise Of Over-Allotment Option
  - 12.2.7 Mar 27, 2007: Abiomed Closes Sale Of Common Stock In Public Offering
  - 12.2.8 Feb 05, 2007: Abiomed Reports Q3 Fiscal 2007 Results
  - 12.2.9 Feb 02, 2007: Abiomed Reports Q3 Fiscal 2006 Results
  - 12.2.10 Nov 08, 2006: Abiomed Reports Q2 Fiscal 2007 Results
  - 12.2.11 Aug 08, 2006: Abiomed Reports Q1 Fiscal 2007 Results
  - 12.2.12 May 08, 2006: Abiomed Reports Q4 Fiscal 2006 Results
- 12.3 Other Significant Developments
  - 12.3.1 May 31, 2007: Abiomed Appoints New Director
  - 12.3.2 Jan 16, 2007: Abiomed Appoints New Board Member
  - 12.3.3 Jan 09, 2006: Abiomed Appoints Lead Director Of Its Board
  - 12.3.4 Dec 19, 2005: Abiomed Appoints New CFO
13 Appendix
- 13.1 Methodology
  - 13.1.1 Coverage
  - 13.1.2 Secondary Research
  - 13.1.3 Primary Research
  - 13.1.4 Expert Panel Validation
- 13.2 Contact Us
- 13.3 About Global Markets Direct
- 13.4 Disclaimer
List of Tables
- Table 1: ABIOMED, Inc.,Key Facts, 2007
- Table 2: ABIOMED, Inc. Pipeline Products by Equipment Type
- Table 3: ABIOMED, Inc. Pipeline Products By Development Stage
- Table 4: ABIOMED, Inc. Pipeline Products By Therapy Area
- Table 5: ABIOMED, Inc. Pipeline Products By Clinical Trials
- Table 6: ABIOMED, Inc. Pipeline Products By News Summaries
- Table 7: ABIOMED, Inc., Key Employees, 2007
- Table 8: ABIOMED, Inc., Subsidiaries
List of Figures
- Figure 1: ABIOMED, Inc. Pipeline Products By Clinical Trials
- Figure 2: ABIOMED, Inc. Pipeline Products By News Summary
- Figure 3: Global Markets Direct Methodology